Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086229
Status:
COMPLETED
Last Update Posted:
2006-08-18
First Post:
2004-06-28
Brief Title:
Absorption and Distribution of Glucosamine and Chondroitin
Sponsor:
National Center for Complementary and Integrative Health NCCIH
Organization:
National Center for Complementary and Integrative Health NCCIH
Study Overview
Official Title:
A Pharmacokinetic Study of Glucosamine and Chondroitin
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine the way the dietary supplements glucosamine and chondroitin are absorbed and distributed throughout the body
Detailed Description:
Osteoarthritis is the most common musculoskeletal disease in the world While predisposing conditions have been identified the actual cause of osteoarthritis remains unknown Traditional treatments most often anti-inflammatory drugs and pain relievers produce variable results and may cause significant toxicity The use of complementary and alternative therapies in the treatment of osteoarthritis has become more common and particular interest has focused on glucosamine and chondroitin treatments This study will examine the pharmacokinetics of glucosamine and chondroitin
This study consists of two phases In Phase I participants will have two study visits during which multiple blood samples will be taken to determine levels of glucosamine and chondroitin found naturally in the body During Phase II participants will be randomly assigned to receive glucosamine chondroitin or a combination of the two for 3 months Blood samples will be taken at each of the three Phase II study visits to examine the pharmacokinetics of glucosamaine and chondroitin
This study consists of two phases In Phase I participants will have two study visits during which multiple blood samples will be taken to determine levels of glucosamine and chondroitin found naturally in the body During Phase II participants will be randomly assigned to receive glucosamine chondroitin or a combination of the two for 3 months Blood samples will be taken at each of the three Phase II study visits to examine the pharmacokinetics of glucosamaine and chondroitin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None